New approaches for temozolomide therapy: Use in newly diagnosed glioma

Seminars in Oncology

Volumn 28, Issue 4 SUPPL. 13, 2001, Pages 19-23

  Stupp, Roger ^a   Newlands, Edward ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; GASTROINTESTINAL HEMORRHAGE; GLIOBLASTOMA; HUMAN; LEUKOPENIA; LYMPHOCYTOPENIA; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

EID: 0034823436     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.26650     Document Type: Review

References (14)

1. Cancer statistics, 2000
2. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
3. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy
4. Future directions in the treatment of malignant gliomas with temozolomide
5. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
6. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
7. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
8. Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme
9. Phase I trial of temozolomide using an extended continuous oral schedule
10. Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
11. The Charing Cross Hospital experience with temozolomide in patients with gliomas
12. DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma
13. Vitro evaluation of temozolomide combined with X-irradiation
14. Promising survival with concomitant and adjuvant temozolomide for newly diagnosed glioblastoma multiforme